UnitedHealth Group shares gain 3% after stronger than expected earnings and guidance

US health insurance giant UnitedHealth Group (UNH.US) reported third-quarter 2026 results that significantly exceeded Wall Street expectations in terms of both revenue and earnings per share. Shares are rising nearly 3% after operating profitability improved and the medical care ratio came in below forecasts, suggesting more effective control over healthcare costs. Another positive development was the upward revision to the company's full-year earnings guidance, although total enrollment figures slightly disappointed.

• Group revenue reached $112.69 billion, compared with expectations of $111.03 billion. Adjusted earnings per share (EPS) came in at $4.69, comfortably exceeding the consensus estimate of $4.12.

• Reported EPS increased to $4.56 from $2.59 a year earlier, representing approximately 76% year-over-year growth and pointing to a substantial recovery in profitability.

• The UnitedHealthcare insurance segment generated $86.33 billion in revenue, exceeding the forecast of $84.87 billion. Optum, which provides healthcare services, pharmacy solutions and analytics, reported revenue of $66.88 billion, slightly above the consensus estimate of $66.48 billion.

• Total enrollment reached 48.3 million, below expectations of 48.62 million. This was one of the weaker aspects of the report, potentially reflecting ongoing competitive pressures or changes in the company's insurance portfolio.

• The medical care ratio (MCR) came in at 88.4%, compared with expectations of 89.9%. A lower ratio means that a smaller proportion of premium revenue was spent on medical benefits, supporting profitability in the insurance business.

• Operating margin improved to 5.8% from 3.8% a year earlier, despite the operating cost ratio reaching 12.8%, slightly above expectations of 12.6%. The margin improvement suggests that the benefits of lower medical costs outweighed pressure from other operating expenses.

• UnitedHealth raised its full-year 2026 adjusted EPS guidance to at least $20.50, up from its previous range of $19.50–$20.00. At the same time, the company increased its reported EPS guidance to at least $19.50, compared with the previous range of $18.45–$18.95, signaling greater management confidence in its performance toward the end of the year.

The results suggest that UnitedHealth's profitability recovery is gaining traction, with the lower-than-expected medical care ratio and upward revision to earnings guidance particularly important for investors. However, sustaining this improvement in the coming quarters will depend on medical cost trends and the stabilization of enrollment levels.

UNH.US Stock Chart (D1 Timeframe)

The stock has endured a challenging period and is still trading approximately 40% below its all-time highs. Recently, shares have attempted to break above the key 200-session exponential moving average (EMA200, red line), and the positive market reaction to the earnings report appears likely to support a breakout above this resistance level, potentially opening the way toward $400 and $440.

Source: xStation5

UnitedHealth Group's revenue remains on a long-term upward trajectory, although recent quarters demonstrate that business expansion does not necessarily translate into a proportional improvement in profitability. In the second quarter of 2026, revenue reached approximately $112 billion, while net income amounted to around $5.5 billion and net profit margin stood at 4.9%, indicating a recovery following a period of elevated cost pressures. Return on invested capital (ROIC) of 14.3% suggests that the company continues to generate meaningful returns on the capital deployed in its business, although this metric alone does not guarantee a sustainable improvement in profitability.

With a trailing price-to-earnings (P/E) ratio of 24.3 and a forward P/E of 19.2, based on expected earnings over the next 12 months, the market appears to be pricing in a continued earnings recovery, even though earnings per share growth has remained virtually flat over the past eight quarters (+0.1% CQGR). The key to UnitedHealth's outlook will therefore be not only maintaining revenue growth but, more importantly, improving margins, controlling medical costs and generating higher returns on invested capital.

Source: XTB Research